Liste des publications GINECO - Cancer Ovaire 2009

Cartaxhy – Poster – 4,87 Mo
L. Gladieff
Monotherapy versus doublet in resistant ovarian cancer: a randomised phase II gineco trial (cartaxhy)
ASCO 2009 (article sous presse) – 2009
TCG – Abstract – 46 ko
AC. Hardy-Bessard
Final results of the GCIG phase III study (AGO-OVAR-9, GINECO-TCG, NSGO-OC-0102): Gemcitabine-Paclitaxel-Carboplatin versus Paclitaxel-Carboplatin as First-line Treatment of Ovarian Cancer
ESGO 2009 (article sous presse) – 2009
TCG – Abstract – 46 ko
J. Herrstedt
A randomized, phase III study (AGO-OVAR-9, GINECO-TCG, NSGO-OC-0102): gemcitabine-paclitaxel-carboplatin (TCG) versus paclitaxel-carboplatin (TC) as firstline treatment of ovarian cancer (OC): survival of FIGO stage I-IIA patients
ESGO 2009 (article sous presse) – 2009
PACA – Article (Anticancer Research)
B. Weber
Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial.
Anticancer Research - Novembre 2009 (réf. PubMed : PMID: 19846972 [PubMed - indexed for MEDLINE] - Anticancer Res. 2009 Oct;29(10):4195-200)
Elogem – Article (British Journal of Cancer) ou Article (PubMed Central)
I. Ray-Coquard
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
British Journal of Cancer – Février 2009 (réf. PubMed : PMID: 19190632 [PubMed - indexed for MEDLINE] - PMCID: PMC2653739 -
Br J Cancer. 2009 Feb 24;100(4):601-7. doi: 10.1038/sj.bjc.6604878. Epub 2009 Feb 3.)

Haut de page

Modifié le 30-08-2016 16:18:57